← brief for 2026-10-17 · Slowing decline

Modern Obesity Treatment: Efficacy, Safety, and Future Directions of GLP-1 (Glucagon-Like Peptide-1) and GIP (Glucose-Dependent Insulinotropic Polypeptide) Receptor Agonists.

Paper No results yet Peer reviewed

Key takeaways

This review summarizes what is known about weight-loss drugs and their effects on the body. It discusses how these drugs help with weight and may protect the kidneys. There are no new results in this paper, as it is a summary of existing studies.

Who did this work

Bartkowiak D · Jakubczyk B · Lasota A · Kopoczynski L · Wiesner M · Wodzinski L · Boguszewski K · Porazinski H · Młynarska A · Ratajski O

Source

Paper · PubMed, Lifestyle and CKD · 2026 Sep 14
https://pubmed.ncbi.nlm.nih.gov/42889249/